Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Gorochov

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Pharmacology|September 20, 2020
When Therapeutic IgA Antibodies Might Come of AgeDelphine Sterlin, Guy Gorochov
Science Translational Medicine|November 12, 2025
EBV and the making of lupusGuy Gorochov, Alexis Mathian
Pharmacology|March 31, 2022
Diversification of IgA Antibody Specificities by Mild Chemical Modification?Guy Gorochov, Stephan von Gunten
Nature Medicine|January 2, 2004
Properties of a disease-specific prion probeGuy Gorochov, Jean-Philippe Deslys
Medecine Sciences : M/S|December 1, 2021
[IgA dominates the early neutralizing antibody response to SARS-CoV-2 virus]Delphine Sterlin, Anouk Malaussena, Guy Gorochov
The New England Journal of Medicine|April 18, 2014
Proteome-wide analysis and CXCL4 in systemic sclerosisAlexis Mathian, Makoto Miyara, Guy Gorochov
The New England Journal of Medicine|October 15, 2011
Antagonistic T-cell subsets in skin diseasesLaurent Arnaud, Martin Larsen, Guy Gorochov
Scientific Reports|June 22, 2016
HIV-specific Th2 and Th17 responses predict HIV vaccine protection efficacyDelphine Sauce, Guy Gorochov, Martin Larsen
Arthritis and Rheumatism|January 31, 2009
Human lupus, fewer Treg cells indeed: comment on the article by Venigalla et alMakoto Miyara, Zahir Amoura, Guy Gorochov
Current Opinion in Allergy and Clinical Immunology|August 13, 2016
Host genetics affect microbial ecosystems via host immunityHela El Kafsi, Guy Gorochov, Martin Larsen
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Pharmacology|September 20, 2020
When Therapeutic IgA Antibodies Might Come of AgeDelphine Sterlin, Guy Gorochov
Science Translational Medicine|November 12, 2025
EBV and the making of lupusGuy Gorochov, Alexis Mathian
Pharmacology|March 31, 2022
Diversification of IgA Antibody Specificities by Mild Chemical Modification?Guy Gorochov, Stephan von Gunten
Nature Medicine|January 2, 2004
Properties of a disease-specific prion probeGuy Gorochov, Jean-Philippe Deslys
Medecine Sciences : M/S|December 1, 2021
[IgA dominates the early neutralizing antibody response to SARS-CoV-2 virus]Delphine Sterlin, Anouk Malaussena, Guy Gorochov
The New England Journal of Medicine|April 18, 2014
Proteome-wide analysis and CXCL4 in systemic sclerosisAlexis Mathian, Makoto Miyara, Guy Gorochov
The New England Journal of Medicine|October 15, 2011
Antagonistic T-cell subsets in skin diseasesLaurent Arnaud, Martin Larsen, Guy Gorochov
Scientific Reports|June 22, 2016
HIV-specific Th2 and Th17 responses predict HIV vaccine protection efficacyDelphine Sauce, Guy Gorochov, Martin Larsen
Arthritis and Rheumatism|January 31, 2009
Human lupus, fewer Treg cells indeed: comment on the article by Venigalla et alMakoto Miyara, Zahir Amoura, Guy Gorochov
Current Opinion in Allergy and Clinical Immunology|August 13, 2016
Host genetics affect microbial ecosystems via host immunityHela El Kafsi, Guy Gorochov, Martin Larsen
Pageof 16